If you have any questions about the videos or this page, please contact our Marketing Specialist, Silvie Pradhan.

(Event) Outsourced Pharma Capacity 2024 - Curia Biologics

Curia presented at the “Outsourced Pharma Capacity Update – Large Molecule Drug Substance & Development” in July 2024. Watch the on-demand presentation as our Vice President of Biologics, Steve Lavezoli explains how we’ve been a critical partner for small, midsize, and even large biotech businesses, supporting all requirements from IND enabling studies through late-stage commercial programs.

Embed